Liminatus Pharma LIMN Cash Flow Statement (2024-2026)

NASDAQ LIMN
$0.11 +0.00 (+0.00%)
At close: Aug 20, 2026 · 4:00 PM EDT
1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter) -0.96M-0.60M-0.38M-0.33M-1.16M-0.72M-0.71M-1.12M
Depreciation and Depletion (Quarter) 542.00543.00518.00
Gains from Investment Securities (Quarter) 0.12M-0.08M-0.09M0.00M
Cash from Operations (Quarter) -1.10M-0.21M-0.14M-0.16M-8.82M-0.60M-0.39M-2.02M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) (Quarter) 542.00543.00518.00
Change in Working Capital
Change in Account Payables (Quarter) -0.00M-0.02M-0.08M0.01M0.03M-0.01M
Change in Accured Expenses (Quarter) -0.02M-0.02M0.03M0.12M-2.16M-2.01M0.02M-0.19M
Investing Activities
Cash from Investing Activities (Quarter) -0.80M-0.55M-0.57M-0.20M-0.01M
Financing Activities
Other financing activities (Quarter) 3.59M
Debt Issuance and Repayment
Short-Term Debt issuances (Quarter) 0.98M0.70M0.71M0.59M3.04M
Misc.
Cash from Financing Activities (Quarter) 1.02M0.70M0.71M10.32M3.59M
Change in Cash (Quarter) -0.40M0.01M0.01M-0.02M1.30M-0.61M-0.39M1.57M
Free Cash Flow (Quarter) -1.10M-0.21M-0.14M-0.16M-8.82M-0.60M-0.39M-2.02M
Net Cash Flow (Quarter) -1.10M0.01M0.01M-0.02M1.30M-0.61M-0.39M1.57M